Is there a link between antibiotic use in childhood and later IBD?

Is the link between childhood antibiotics and IBD real?

Yes, the evidence is strong and consistent. A 2025 meta-analysis (the gold standard for combining research) pooled data from 8 high-quality studies and found that childhood antibiotic exposure was associated with a 42% higher risk of developing IBD later in life [1]. This finding was not a fluke: the same analysis found a 59% higher risk for Crohn's disease specifically, and a 23% higher risk for ulcerative colitis [1]. Another large meta-analysis from 2024, which included 28 studies and over 150,000 IBD patients, confirmed a 41% increased risk for new-onset IBD after antibiotic exposure [3].

The link holds across different countries and populations. A nationwide Danish study of over 6 million people found that antibiotic use was associated with a higher risk of IBD in every age group, including children [7]. A large study from Korea, a non-Western country, also found a clear link, showing that antibiotics in the first year of life increased the risk of childhood-onset IBD by 51% [5]. This consistency across different populations makes the finding very robust.

Does the number of antibiotic courses or the type matter?

Yes, the risk is dose-dependent: the more antibiotics a child receives, the higher the risk. A Danish study found that children who had 4 or more antibiotic prescriptions had a 33% higher risk of pediatric IBD compared to those who had none [2]. A Norwegian study showed that receiving more than 2 antibiotic courses before age 2 increased the odds of pediatric IBD by 47% [8]. This 'dose-response' relationship is a strong clue that the link is causal, not just a coincidence.

The type of antibiotic also matters. Broad-spectrum antibiotics, which kill a wider range of bacteria, appear to be riskier than narrow-spectrum ones. The Danish study found that broad-spectrum antibiotics increased the risk of pediatric IBD by 29% compared to narrow-spectrum ones [2]. A Norwegian study reported an even stronger effect: broad-spectrum antibiotics before age 2 were linked to a 157% increase in the odds of pediatric IBD [8]. Certain classes of antibiotics, like metronidazole and quinolones (often used for gut infections), were associated with the highest risk in a large meta-analysis [3].

Could it be the infections themselves, not the antibiotics?

This is a key question, and the research suggests the antibiotics themselves are a major factor, independent of the infections they treat. A large Scandinavian study that pooled data from over 100,000 children specifically adjusted for the number of infections a child had. Even after this adjustment, antibiotic use in the first year of life was still linked to a 33% higher risk of IBD [4]. This means the association is not simply because sicker children get more infections and also get more antibiotics.

Further supporting this, a 2025 meta-analysis found that adjusting for infections did not weaken the link between childhood antibiotics and IBD [1]. While infections themselves may play a role (one study found a history of childhood infections raised IBD odds [6]), the evidence points to antibiotics as an independent and significant risk factor.

About These Sources

This answer is built on 8 peer-reviewed studies — published from 2023 to 2025, 5 from 2024 or later, 6 in Q1 journals, collectively cited 188 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 59 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions